Astria Therapeutics, Inc.
Clinical trials sponsored by Astria Therapeutics, Inc., explained in plain language.
-
New hope for Long-Term control of rare swelling disorder
Disease control ENROLLING_BY_INVITATIONThis study aims to evaluate the long-term safety and effectiveness of navenibart for people with hereditary angioedema (HAE), a rare condition causing sudden, severe swelling. The trial involves 145 adults and adolescents who previously participated in an earlier study of the sam…
Phase: PHASE3 • Sponsor: Astria Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First humans receive experimental drug in early safety test
Knowledge-focused OngoingThis is the first study testing a new drug called STAR-0310 in humans. Researchers are giving single doses to 40 healthy adults to check for side effects and see how the body processes the medication. The study will help determine if STAR-0310 is safe enough for future testing in…
Phase: PHASE1 • Sponsor: Astria Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Apr 02, 2026 06:56 UTC